Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05361070 · ClinicalTrials.gov registry record
Neonatal Seizure Registry, GEnetics of Post-Neonatal Epilepsy
A clinical trial of Stroke and Epilepsy, sponsored by University of California, San Francisco.
- Active
- Registry status
- 300
- Enrollment target
- 8
- Study locations
NCT05361070 is a study of Stroke and Epilepsy that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 300 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower). The trial reports 8 study locations across 7 states.
The verdict
NCT05361070, a study of Stroke and Epilepsy, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 8
- Study locations
Study Summary
The NSR-GENE study is a longitudinal cohort study of approximately 300 parent-child trios from the Neonatal Seizure Registry and participating site outpatient clinics that aims to evaluate whether and how genes alter the risk of post-neonatal epilepsy among children with acute provoked neonatal seizures. The researchers aim to develop prediction rules to stratify neonates into low, medium, and high risk for post-neonatal epilepsy based on clinical, electroencephalogram (EEG), magnetic resonance imaging (MRI), and genetic risk factors.
Conditions Studied
Study Locations (8)
Massachusetts
- Massachusetts General Hospital - Boston
- Boston Children's Hospital - Boston
California
- University of California, San Francisco - San Francisco
District of Columbia
- Children's National Medical Center - Washington D.C.
Michigan
- University of Michigan - Ann Arbor
North Carolina
- Duke University - Durham
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2022-08-09 |
| Est. Completion | 2027-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05361070
The ClinicalTrials.gov registry entry for NCT05361070 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Stroke appearing as the primary indexed condition, and to 0 interventions.
NCT05361070 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Massachusetts, California, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05361070 about?
NCT05361070 is a clinical study titled "Neonatal Seizure Registry, GEnetics of Post-Neonatal Epilepsy". The NSR-GENE study is a longitudinal cohort study of approximately 300 parent-child trios from the Neonatal Seizure Registry and participating site outpatient clinics that aims to evaluate whether and how genes alter the risk of post-neonatal epilepsy among children with acute provoked neonatal seiz...
What is the current status of trial NCT05361070?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2022-08-09. Estimated completion is 2027-02-28.
What conditions does trial NCT05361070 study?
This clinical trial studies the following conditions: Stroke, Epilepsy, Hypoxic Ischemic Encephalopathy, Intracranial Hemorrhage, Gene Abnormality.
Who is sponsoring clinical trial NCT05361070?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05361070 being conducted?
This trial has 8 study locations across California, District of Columbia, Massachusetts, Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
RECRUITING
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
RECRUITING
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.